Moderate Variation of the Oncogenic Potential Among High-Risk Human Papillomavirus Types in Gynecologic Patients With Cervical Abnormalities

Journal of Medical Virology

Volumn 71, Issue 4, 2003, Pages 585-592

  Szoke, Krisztina ^a   Sápy, Tamás ^a   Krasznai, Zoárd ^a   Hernádi, Zoltán ^a   Szládek, Györgyi ^b   Veress, György ^a   Dillner, Joakim ^c   Gergely, Lajos ^a,b   Kónya, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cervical intraepithelial neoplasia; HPV genotype; Hybrid capture HPV test; Viral load

Indexed keywords

ADULT; ARTICLE; CARCINOGENESIS; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; UTERINE CERVICITIS; VARIATION (GENETICS);

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0142151255     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10526     Document Type: Article

References (37)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87:796-802.
2. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz AT. 2002a. Restricted cross-reactivity of Hybrid Capture 2 with non-oncogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11:1394-1399.
3. Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A, Schussler JE, Burk RD. 2002b. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 68:417-423.
4. Cho NH, An HJ, Jeong K, Kang S, Kim JW, Park TK. 2003. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis. Am J Obstet Gynecol 188:56-62.
5. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Gabriel R, Quereux C, Birembaut P. 1999. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1,518 women. Br J Cancer 80:1306-1311.
6. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172:946-954.
7. Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J. 2002. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol 100:965-971.
8. Franco EL, Rohan TE, Villa LL. 1999. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91:506-511.
9. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. 2003. A comparison between real-time polymerase chain reaction and Hybrid Capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12(6):477-484.
10. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
11. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti M, Sherman M, Scarpidis U, Lin Q, Terai M, Bromley R, Buetow K, Apple R, Burk R. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
12. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1371.
13. Kónya J, Veress G, Hernádi Z, Soós G, Czeglédy J, Gergely L. 1995. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias. J Med Virol 46:1-6.
14. Kónya J, Veress G, Juhász A, Szarka K, Sápy T, Hernádi Z, Gergely L. 2000. Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia. J Clin Microbiol 38:408-411.
15. Kalantari M, Karlsen F, Johansson B, Sigurjonsson T, Warleby B, Hagmar B. 1997. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: A study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol 28:899-904.
16. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ. 2002. Type specific persistence of high-risk human papillomavirus (HPV) as indicator of high-grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. BMJ 325:572.
17. Kjellberg L, Wiklund F, Sjoberg I, Wadell G, Angstrom T, Dillner J, Mahlck CG. 1998. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia. Am J Obstet Gynecol 179:1497-1502.
18. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. 1992. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337.
19. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228-229.
20. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. 1999. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605-1610.
21. Meyer T, Arndt R, Beckmann E, Padberg B, Christophers E, Stockfleth E. 2001. Distribution of HPV 53, HPV 73, and CP8304 in genital epithelial lesions with different grades of dysplasia. Int J Gynecol Cancer 11:198-204.
22. Munoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19:1-5.
23. Munoz N, Bosch FX, Sanjosé de S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
24. Nindl I, Lotz B, Kuhne Heid R, Endisch U, Schneider A. 1999. Distribution of 14 high-risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay. J Clin Pathol 52:17-22.
25. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 354:20-25.
26. Nobbenhuis M, Meijer C, van den Brule A, Rozendaal L, Voorhorst F, Risse E, Verheijen R, Helmerhorst T. 2001. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84:796-801.
27. Poljak M, Marin IJ, Seme K, Vince A. 2002. Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25:89-97.
28. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
29. Schiffman MH, Kiviat NB, Burk RD, Shah KV, Daniel RW, Lewis R, Kuypers J, Manos MM, Scott DR, Sherman ME, et al. 1995. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 33: 545-550.
30. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103(4):519-524.
31. Tachezy R, Hamsikova E, Hajek T, Mikyskova I, Smahel M, Van Ranst M, Kanka J, Havrankova A, Rob L, Guttner V, Slavik V, Anton M, Kratochvil B, Kotrsova L, Vonka V. 1999. Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol 58:378-386.
32. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40(3): 779-787.
33. van Doorn LJ, Quint W, Kleter B, Molijn A, Colau B, Martin MT, Kravang In, Torrez-Martinez N, Peyton CL, Wheeler CM. 2002. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 40:979-983.
34. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, van den Brule AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance. Int J Cancer 98(4):590-595.
35. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
36. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. 1999. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638.
37. Woodman CBJ, Collins S, Rollason TP, Winter H, Bailey A, Yates M, Young LS. 2003. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet 361:40-43.